{
    "title": "Sage scraps seizure drug study after trial failure, shares slump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4876096/Sages-seizure-drug-fails-key-trial-shares-slump.html",
    "date": "2017-09-12",
    "keywords": [
        "drug",
        "srse",
        "study",
        "percent",
        "trial",
        "status",
        "epilepticus",
        "sage",
        "patient",
        "divya",
        "grover",
        "seizure",
        "disorder",
        "treatment",
        "goal",
        "brexanolone",
        "conference",
        "call",
        "postpartum",
        "depression",
        "ppd",
        "matteis",
        "antiseizure",
        "coma",
        "year",
        "inc",
        "key",
        "biggestever",
        "percentage",
        "loss",
        "morning",
        "trade",
        "latestage",
        "company",
        "decision",
        "sense",
        "lack",
        "efficacy",
        "signal",
        "analyst",
        "paul",
        "client",
        "note",
        "use",
        "july",
        "midstage",
        "result",
        "way",
        "phase",
        "form",
        "time",
        "class",
        "line",
        "standardofcare",
        "complexity",
        "hedge",
        "fund",
        "kerrisdale",
        "capital",
        "stock",
        "httpreutrs2wvaxer",
        "subgroup",
        "effect",
        "size",
        "food",
        "administration",
        "reporting",
        "bengaluru",
        "editing",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}